CONMED Statistics
Total Valuation
CONMED has a market cap or net worth of $2.19 billion. The enterprise value is $3.14 billion.
Market Cap | 2.19B |
Enterprise Value | 3.14B |
Important Dates
The next confirmed earnings date is Wednesday, July 31, 2024, after market close.
Earnings Date | Jul 31, 2024 |
Ex-Dividend Date | Jun 14, 2024 |
Share Statistics
CONMED has 30.80 million shares outstanding. The number of shares has increased by 0.88% in one year.
Shares Outstanding | 30.80M |
Shares Change (YoY) | +0.88% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 0.56% |
Owned by Institutions (%) | 117.17% |
Float | 30.53M |
Valuation Ratios
The trailing PE ratio is 27.19 and the forward PE ratio is 15.16. CONMED's PEG ratio is 5.29.
PE Ratio | 27.19 |
Forward PE | 15.16 |
PS Ratio | 1.73 |
Forward PS | 1.57 |
PB Ratio | 2.56 |
P/FCF Ratio | 15.45 |
PEG Ratio | 5.29 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.75, with an EV/FCF ratio of 22.21.
EV / Earnings | 38.16 |
EV / Sales | 2.49 |
EV / EBITDA | 19.75 |
EV / EBIT | 21.99 |
EV / FCF | 22.21 |
Financial Position
The company has a current ratio of 2.18, with a Debt / Equity ratio of 1.16.
Current Ratio | 2.18 |
Quick Ratio | 0.94 |
Debt / Equity | 1.16 |
Debt / EBITDA | 6.23 |
Debt / FCF | 7.00 |
Interest Coverage | 3.65 |
Financial Efficiency
Return on equity (ROE) is 10.10% and return on invested capital (ROIC) is 6.14%.
Return on Equity (ROE) | 10.10% |
Return on Assets (ROA) | 3.60% |
Return on Capital (ROIC) | 6.14% |
Revenue Per Employee | $315,387 |
Profits Per Employee | $20,587 |
Employee Count | 4,000 |
Asset Turnover | 0.55 |
Inventory Turnover | 1.73 |
Taxes
In the past 12 months, CONMED has paid $21.46 million in taxes.
Income Tax | 21.46M |
Effective Tax Rate | 20.67% |
Stock Price Statistics
The stock price has decreased by -46.63% in the last 52 weeks. The beta is 1.43, so CONMED's price volatility has been higher than the market average.
Beta (5Y) | 1.43 |
52-Week Price Change | -46.63% |
50-Day Moving Average | 71.55 |
200-Day Moving Average | 87.04 |
Relative Strength Index (RSI) | 53.12 |
Average Volume (20 Days) | 401,867 |
Short Selling Information
The latest short interest is 846,967, so 2.75% of the outstanding shares have been sold short.
Short Interest | 846,967 |
Short Previous Month | 1.02M |
Short % of Shares Out | 2.75% |
Short % of Float | 2.77% |
Short Ratio (days to cover) | 9.27 |
Income Statement
In the last 12 months, CONMED had revenue of $1.26 billion and earned $82.35 million in profits. Earnings per share was $2.61.
Revenue | 1.26B |
Gross Profit | 692.89M |
Operating Income | 142.92M |
Pretax Income | 103.80M |
Net Income | 82.35M |
EBITDA | 159.11M |
EBIT | 142.92M |
Earnings Per Share (EPS) | $2.61 |
Balance Sheet
The company has $33.86 million in cash and $990.80 million in debt, giving a net cash position of -$956.95 million or -$31.07 per share.
Cash & Cash Equivalents | 33.86M |
Total Debt | 990.80M |
Net Cash | -956.95M |
Net Cash Per Share | -$31.07 |
Equity (Book Value) | 854.66M |
Book Value Per Share | 27.75 |
Working Capital | 344.32M |
Cash Flow
In the last 12 months, operating cash flow was $158.32 million and capital expenditures -$16.81 million, giving a free cash flow of $141.50 million.
Operating Cash Flow | 158.32M |
Capital Expenditures | -16.81M |
Free Cash Flow | 141.50M |
FCF Per Share | $4.60 |
Margins
Gross margin is 54.92%, with operating and profit margins of 11.33% and 6.53%.
Gross Margin | 54.92% |
Operating Margin | 11.33% |
Pretax Margin | 8.23% |
Profit Margin | 6.53% |
EBITDA Margin | 12.61% |
EBIT Margin | 11.33% |
FCF Margin | 11.22% |
Dividends & Yields
This stock pays an annual dividend of $0.80, which amounts to a dividend yield of 1.13%.
Dividend Per Share | $0.80 |
Dividend Yield | 1.13% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 30.65% |
Buyback Yield | -0.88% |
Shareholder Yield | 0.25% |
Earnings Yield | 3.77% |
FCF Yield | 6.47% |
Analyst Forecast
The average price target for CONMED is $101.86, which is 43.55% higher than the current price. The consensus rating is "Buy".
Price Target | $101.86 |
Price Target Difference | 43.55% |
Analyst Consensus | Buy |
Analyst Count | 7 |
Revenue Growth Forecast (5Y) | 8.10% |
EPS Growth Forecast (5Y) | 39.07% |
Stock Splits
The last stock split was on September 10, 2001. It was a forward split with a ratio of 3:2.
Last Split Date | Sep 10, 2001 |
Split Type | Forward |
Split Ratio | 3:2 |
Scores
CONMED has an Altman Z-Score of 2.11 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.11 |
Piotroski F-Score | 8 |